Hubei Jumpcan Pharmaceutical unit obtains high-tech enterprise recognition and to enjoy tax preference
March 12(Reuters) - Hubei Jumpcan Pharmaceutical Co Ltd <600566.SS>:Says its wholly owned subsidiary was recognized as high-tech enterprise again, and to enjoy a tax preference of 15 percent for three years from 2017 to 2019.
Latest Developments forHubei Jumpcan Pharmaceutical Co Ltd
Latest Key Developments inPharmaceuticals
- Guizhou Bailing Group Pharmaceutical's 2018 And Q1 Net Profit Up From Year Earlier
- Teva Announces Update On Fremanezumab Clinical Development For Use In Episodic Cluster Headache
- Boya Bio-Pharmaceutical's 2018 And Q1 Net Profit Up From Year Earlier
- Xin Jiang Ready Health's 2018 And Q1 Net Profit Up From Year Earlier